Showing results (21-30 of 262) with videos related to
Sort By:
Pageof 27
British Medical Bulletin|July 1, 1996
Advances in psychopharmacology: mood disorders and dementiaP J CowenPostgraduate Medical Journal|September 1, 1979
Toxic psychosis with antihistamines reversed by physostigmineP J CowenArchives of General Psychiatry|February 9, 2000
Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatmentP A Sargent, K H Kjaer, C J Bench, et al.Pharmacopsychiatry|August 24, 2001
Researching the antidepressant actions of Hypericum perforatum (St. John's wort) in animals and manM Franklin, P J CowenPsychological Medicine|April 30, 2008
'It's not over when it's over': persistent neurobiological abnormalities in recovered depressed patientsZ Bhagwagar, P J CowenPharmacopsychiatry|August 24, 2001
Effect of a low tryptophan diet on the prolactin responses to the 5-HT2A agonist DOI in the ratM Franklin, P J CowenEuropean Journal of Pharmacology|April 10, 1990
Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptorsS E Gartside, P J CowenPsychopharmacology|January 1, 1986
Clomipramine enhances prolactin and growth hormone responses to L-tryptophanI M Anderson, P J CowenBiological Psychiatry|September 1, 1994
The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteersP H Silverstone, P J CowenJournal of Clinical Psychopharmacology|August 1, 1994
Attenuation of the prolactin-stimulating and hyperthermic effects of nefazodone after subacute treatmentA E Walsh, P J CowenPageof 27